Nabota

Description

NABOTA is a botulinum toxin type A developed by Daewoong Pharmaceutical Co., Ltd., one of South Korea's most important biopharmaceutical companies, with more than 30 years of experience in biotechnology.
It is the first Korean product approved by the U.S. FDA, establishing itself as an effective and affordable alternative to Botox, with the same potency and no need to modify handling protocols.

NABOTA works by relaxing the muscles responsible for dynamic wrinkles, achieving smoother, rejuvenated skin without creating a stiff or “frozen” look. It offers fast onset of action, high purity and long-lasting results with excellent tolerance and clinical safety.

Benefits

• First Korean botulinum toxin approved by the FDA.
• Fast effect and long-lasting results.
• Safe, economical alternative to Botox.
• Does not cause facial stiffness or artificial expressions.
• High purity and international quality control.
• Excellent safety profile for doctors and patients.

Treatment areas

• Forehead and glabella
• Crow's feet
• Nasolabial folds
• Periorbital and perioral area
• Neck
• Blepharospasm
• Hyperhidrosis
• Facial lifting with toxin

Main ingredients

Clostridium Botulinum Toxin Type A (strain: Clostridium Botulinum CBFC26)

Packaging

NABOTA 100U: 1 vial (100 units per box)
NABOTA 200U: 1 vial (200 units per box)

Both presentations share the same formula, potency and effectiveness, varying only in the number of units per vial.

Frequently asked questions

What makes Nabota different from other botulinum toxins?
It is the first Korean botulinum toxin with FDA approval, ensuring high standards of purity, stability and safety.

How long do results last?
Between 4 and 6 months, depending on the treated area, the technique used and the patient's individual response.

When do the effects start to show?
Usually 2 to 5 days after treatment, with full results in 10 to 14 days.

Does it cause facial stiffness?
No. Nabota acts only on the treated muscles, maintaining natural facial expressions.

Who can administer Nabota?
It must be administered exclusively by medical professionals trained in the use of botulinum toxin.